Cytokinetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CYTK Key Statistics
CYTK News
Loading... Loading... Cytokinetics's CYTK short percent of float has fallen 11.8% since its last report. The company recently reported that it has 13.23 millio...
Cytokinetics (CYTK) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2024. Thi...
Cytokinetics, Incorporated SOUTH SAN FRANCISCO, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced it will ho...
Analyst ratings
83%
of 18 ratingsMore CYTK News
Cytokinetics (CYTK) has shared an update. Sung H. Lee is set to join Cytokinetics, Incorporated as the Executive Vice President and Chief Financial Officer sta...
In a regulatory filing, Cytokinetics disclosed that on April 23, the company entered into an employment offer letter with Sung Lee, pursuant to which Lee has ag...